Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07030023 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Diagnosis of Wire Syndrome

StatusCompleted
PhaseNot specified
Started2025-03-28
View on ClinicalTrials.gov ↗

Amendment history

2026-09-19
notable
Trial status changed: Enrolling by Invitation → Completed
Final enrollment: 53 participants (planned 40)
Primary completion 2026-01-31, at least 184 days after the final estimate of 2025-07-31
The Wire Syndrome (WS) refers to aberrant, unexpected, unexplained, or excessive dental movements involving teeth held by an intact post-orthodontic retention wire. Its prevalence ranging from 1.1% to 43%. It is a chronic, progressive pathological process, generally asymptomatic, resulting in a new malocclusion that is not due to relapse or a physiological process, and whose aesthetic and/or functional dento-periodontal consequences are harmful. The causes are multifactorial origin. In the early stages of Wire Syndrome, dental and periodontal consequences are minors. These issues are thought to progressively worsen over time.However, to date, no author has proposed an appropriate diagnostic approach. Indeed, several diagnostic criteria have been reported in the literature, but their hierarchical ranking, in terms of importance and specificity, has yet to be determined. The main objective of this study is therefore to propose a classification of WS according to its severity, based on a shared framework between periodontists and orthodontists. This classification should, facilitate early detection of the syndrome, and reduce diagnostic delays and therapeutic errors. It should also help clarify prognosis and improve interprofessional collaboration in developing personalized treatment plans.
Trial Details
NCT Number NCT07030023
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Orthodontic Wires
Enrollment 53 participants
Start Date 2025-03-28
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-28